Zuzanna Pietralik-Molińska

Dr. Zuzanna Pietralik-Molińska


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
JSJustyna Sawicka
Justyna Sawicka
EIEmilia Iłowska
Emilia Iłowska
MDMilena Deptuła-Knioła
Milena Deptuła-Knioła
PSPaweł Sosnowski
Paweł Sosnowski
PSPiotr Sass
Piotr Sass
SRSylwia Rodziewicz-Motowidło
Sylwia Rodziewicz-Motowidło
Technological developments in the field of biologically active peptide applications in medicine have increased the need for new methods for peptide delivery. The disadvantage of peptides as drugs is their low biological stability. Recently, great attention has been paid to self-assembling peptides that can form fibrils. Such a formulation makes bioactive peptides more resistant to enzymatic degradation and druggable. Peptide fibrils can be carriers for peptides with interesting biological activities. These features open up prospects for using the peptide fibrils as long-acting drugs and are a valid alternative to conventional peptidic therapies. In our study, we designed new peptide scaffolds that are a hybrid of three interconnected amino acid sequences and are: pro-regenerative, cleavable by neutrophilic elastase, and fibril-forming. We intended to obtain peptides that are stable in the wound environment and that, when applied, would release a biologically active sequence. Our studies showed that the designed hybrid peptides show a high tendency toward regular fibril formation and are able to release the pro-regenerative sequence. Cytotoxicity studies showed that all the designed peptides were safe, did not cause cytotoxic effects and revealed a pro-regenerative potential in human fibroblast and keratinocyte cell lines. In vivo experiments in a dorsal skin injury model in mice indicated that two tested peptides moderately promote tissue repair in their free form. Our research proves that peptide fibrils can be a druggable form and a scaffold for active peptides.

17 July 2019 in RSC Advances
Verified
Journal Article
Open access
PDF file
MGMaciej Gielnik
Maciej Gielnik
ZPZuzanna Pietralik-Molińska
Zuzanna Pietralik-Molińska
IZIgor Zhukov
Igor Zhukov
ASAneta Szymańska
Aneta Szymańska
WKWojciech M. Kwiatek
Wojciech M. Kwiatek
MKMaciej Kozak
Maciej Kozak
Zinc ions modulate the aggregation of PrP (58–93) amyloid peptide.

1 July 2014 in Polimery
Verified
Journal Article
Closed access
WAWeronika Andrzejewska
Weronika Andrzejewska
ZPZuzanna Pietralik-Molińska
Zuzanna Pietralik-Molińska
MTMichał Taube
Michał Taube
ASAndrzej Skrzypczak
Andrzej Skrzypczak
MKMaciej Kozak
Maciej Kozak

23 May 2016 in Chemphyschem
Verified
Journal Article
Closed access
PDF file
ZPZuzanna Pietralik-Molińska
Zuzanna Pietralik-Molińska
ASAndrzej Skrzypczak
Andrzej Skrzypczak
MKMaciej Kozak
Maciej Kozak

1 December 2015 in Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms
Verified
Journal Article
Closed access
MBMateusz Balcerzak
Mateusz Balcerzak
ZPZuzanna Pietralik-Molińska
Zuzanna Pietralik-Molińska
LDLudwik Domka
Ludwik Domka
ASAndrzej Skrzypczak
Andrzej Skrzypczak
MKMaciej Kozak
Maciej Kozak

Verified
Journal Article
Open access
PDF file
ŻPŻaneta Polańska
Żaneta Polańska
ZPZuzanna Pietralik-Molińska
Zuzanna Pietralik-Molińska
DWDaria Wojciechowska
Daria Wojciechowska
AMAugustyn Moliński
Augustyn Moliński
MWMarek Weiss
Marek Weiss
MKMaciej Kozak
Maciej Kozak
Nonviral vectors for gene therapy such as lipoplexes are characterized by low toxicity, high biocompatibility, and good transfection efficiency. Specifically, lipoplexes based on polymeric surfactants and phospholipids have great potential as gene carriers due to the increased ability to bind genetic material (multiplied positive electric charge) while lowering undesirable effects (the presence of lipids makes the system more like natural membranes). This study aimed to test the ability to bind and release genetic material by lipoplexes based on trimeric surfactants and lipid formulations of different compositions and to characterize formed complexes by circular dichroism (CD) spectroscopy and atomic force microscopy (AFM). The cytotoxicity of studied lipoplexes was tested on HeLa cells by the MTT cell viability assay and the dye exclusion test (trypan blue). The presence of lipids in the system lowered the surfactant concentration required for complexation (higher efficiency) and reduced the cytotoxicity of lipoplexes. Surfactant/lipids/DNA complexes were more stable than surfactant/DNA complexes. Surfactant molecules induced the genetic material condensation, but the presence of lipids significantly intensified this process. Systems based on trimeric surfactants and lipid formulations, particularly TRI_N and TRI_IMI systems, could be used as delivery carrier, and have proven to be highly effective, nontoxic, and universal for DNA of various lengths.